Home Healthcare Pharmaceuticals Rheumatoid Arthritis Market

Rheumatoid Arthritis Market Size, Share & Trends Analysis Report By Drug Type (Pharmaceuticals, Biologics & Biosimilars), By Sales Channel (Prescription, Over-the-Counter) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
  7. North America Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
  8. Europe Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
  9. APAC Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
  10. Middle East and Africa Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
  11. LATAM Rheumatoid Arthritis Market Size Analysis
    1. Introduction
    2. Rheumatoid Arthritis Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Pharmaceuticals
        1. Non-steroidal Anti-inflammatory Drugs
        2. Corticosteroids
        3. Analgesics
        4. Others
      2. Biologics & Biosimilars
        1. TNF-α antagonists
        2. T-cell inhibitors
        3. CD20 antigen
        4. JAK inhibitors
        5. Others
    3. Rheumatoid Arthritis Market Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
      1. Prescription
      2. Over-the-Counter
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Pharmaceuticals
          1. Non-steroidal Anti-inflammatory Drugs
          2. Corticosteroids
          3. Analgesics
          4. Others
        2. Biologics & Biosimilars
          1. TNF-α antagonists
          2. T-cell inhibitors
          3. CD20 antigen
          4. JAK inhibitors
          5. Others
      3. Market Size & Forecast By Sales Channel 2022-2034 (USD MILLION/ Units)
        1. Prescription
        2. Over-the-Counter
  12. Competitive Landscape
    1. Rheumatoid Arthritis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AbbVie Inc. (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc. (US)
    3. Amgen Inc. (US)
    4. Johnson & Johnson Services Inc. (US)
    5. Bristol Myers Squibb (US)
    6. Hoffmann-La Roche Ltd. (Switzerland)
    7. Lilly (US)
    8. UCB (Belgium)
    9. Novartis AG (Switzerland)
    10. Sanofi (France)
    11. Merck & Co., Inc. (US)
    12. Gilead Sciences Inc. (US)
    13. Regeneron Pharmaceuticals (US)
    14. Boehringer Ingelheim (Germany)
    15. Celltrion (South Korea)
    16. Samsung Bioepis (South Korea)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Rheumatoid Arthritis Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 3: Global Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 4: North America Rheumatoid Arthritis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 6: North America Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 7: U.S. Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 8: U.S. Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 9: Canada Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Canada Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 11: Europe Rheumatoid Arthritis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 13: Europe Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 14: U.K. Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 15: U.K. Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 16: Germany Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 17: Germany Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 18: France Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 19: France Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 20: Spain Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 21: Spain Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 22: Italy Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 23: Italy Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 24: Russia Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 25: Russia Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 26: Nordic Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 27: Nordic Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 28: Benelux Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 29: Benelux Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 30: Rest of Europe Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 31: Rest of Europe Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 32: APAC Rheumatoid Arthritis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 34: APAC Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 35: China Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 36: China Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 37: Korea Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 38: Korea Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 39: Japan Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 40: Japan Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 41: India Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 42: India Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 43: Australia Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 44: Australia Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 45: Singapore Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 46: Singapore Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 47: Taiwan Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 48: Taiwan Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 49: South East Asia Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 50: South East Asia Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 51: Rest of Asia-Pacific Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 52: Rest of Asia-Pacific Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Rheumatoid Arthritis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 54: Middle East and Africa Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 55: Middle East and Africa Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 56: UAE Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 57: UAE Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 58: Turkey Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 59: Turkey Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 60: Saudi Arabia Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 61: Saudi Arabia Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 62: South Africa Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 63: South Africa Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 64: Egypt Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 65: Egypt Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 66: Nigeria Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 67: Nigeria Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 68: Rest of MEA Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 69: Rest of MEA Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 70: LATAM Rheumatoid Arthritis Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 71: LATAM Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 72: LATAM Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 73: Brazil Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 74: Brazil Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 75: Mexico Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 76: Mexico Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 77: Argentina Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 78: Argentina Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 79: Chile Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 80: Chile Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 81: Colombia Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 82: Colombia Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Table 83: Rest of LATAM Rheumatoid Arthritis Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 84: Rest of LATAM Rheumatoid Arthritis Market Size and Forecast By Sales Channel - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.